Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kevin Purves"'
Autor:
Kevin Purves, Hannah Brown, Ruth Haverty, Andrew Ryan, Laura L. Griffin, Janet McCormack, Sophie O’Reilly, Patrick W. Mallon, Virginie Gautier, Joseph P. Cassidy, Aurelie Fabre, Michael J. Carr, Gabriel Gonzalez, Simone Ciuti, Nicola F. Fletcher
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 8, Pp 1609-1620 (2024)
SARS-CoV-2 can infect wildlife, and SARS-CoV-2 variants of concern might expand into novel animal reservoirs, potentially by reverse zoonosis. White-tailed deer and mule deer of North America are the only deer species in which SARS-CoV-2 has been doc
Externí odkaz:
https://doaj.org/article/ae21f0b7eb5a4d8a82457a952e0ca72b
Autor:
Kevin Purves, Lynsey Macintyre, Debra Brennan, Guðmundur Ó. Hreggviðsson, Eva Kuttner, Margrét E. Ásgeirsdóttir, Louise C. Young, David H. Green, Ruangelie Edrada-Ebel, Katherine R. Duncan
Publikováno v:
Metabolites, Vol 6, Iss 1, p 2 (2016)
The oceans represent an understudied resource for the isolation of bacteria with the potential to produce novel secondary metabolites. In particular, actinomyces are well known to produce chemically diverse metabolites with a wide range of biological
Externí odkaz:
https://doaj.org/article/34eda60381aa464a8a78feb93ec1a30a
Autor:
Kevin Purves, Ruth Haverty, Tiina O'Neill, David Folan, Sophie O'Reilly, Alan W. Baird, Dimitri Scholz, Patrick W. Mallon, Virginie Gautier, Michael Folan, Nicola F. Fletcher
Publikováno v:
Journal of General Virology. 104
A novel proprietary formulation, ViruSAL, has previously been demonstrated to inhibit diverse enveloped viral infections in vitro and in vivo. We evaluated the ability of ViruSAL to inhibit SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2)
Autor:
Kevin Purves, Ruth Haverty, Tiina O’Neill, David Folan, Sophie O’Reilly, Alan W. Baird, Dimitri Scholz, Patrick W Mallon, Virginie Gautier, Michael Folan, Nicola F Fletcher
A novel proprietary formulation, ViruSAL, has previously been demonstrated to inhibit diverse enveloped viral infections in vitro and in vivo. We evaluated the ability of ViruSAL to inhibit SARS-CoV-2 infectivity, using physiologically relevant model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66999a3001716a00a7fad42bf49d3f09
https://doi.org/10.1101/2022.10.05.510928
https://doi.org/10.1101/2022.10.05.510928
Autor:
Guðmundur Óli Hreggviðsson, David H. Green, Eva Kuttner, Debra Brennan, Katherine R. Duncan, RuAngelie Edrada-Ebel, Lynsey MacIntyre, Margrét E. Ásgeirsdóttir, Kevin Purves, Louise C. Young
Publikováno v:
Metabolites, Vol 6, Iss 1, p 2 (2016)
Metabolites; Volume 6; Issue 1; Pages: 2
Metabolites
Metabolites; Volume 6; Issue 1; Pages: 2
Metabolites
The oceans represent an understudied resource for the isolation of bacteria with the potential to produce novel secondary metabolites. In particular, actinomyces are well known to produce chemically diverse metabolites with a wide range of biological